Ossiam Abbott Laboratories Transaction History

Ossiam

$5.1 Billion
Q3 2024

A detailed history of Ossiam transactions in Abbott Laboratories stock. As of the latest transaction made, Ossiam holds 39,905 shares of ABT stock, worth $4.58 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

39,905

Previous 47,358 15.74%

Holding current value

$4.58 Million

Previous $4.92 Million 7.54%

% of portfolio

0.09%

Previous 0.09%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $745,821 - $880,422	-7,453 Reduced 15.74%	39,905 $4.55 Million
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $634,196 - $707,922	6,296 Added 15.33%	47,358 $4.92 Million
Q1 2024 May 13, 2024	BUY	$109.52 - $120.96 $362,511 - $400,377	3,310 Added 8.77%	41,062 $4.67 Million
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $226,737 - $277,545	2,514 Added 7.13%	37,752 $4.16 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $1.15 Million - $1.38 Million	12,022 Added 51.78%	35,238 $3.41 Million
Q2 2023 Aug 11, 2023	BUY	$100.78 - $112.29 $905,407 - $1.01 Million	8,984 Added 63.13%	23,216 $2.53 Million
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $48,430 - $57,005	-500 Reduced 3.39%	14,232 $1.44 Million
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $828,162 - $971,562	-8,712 Reduced 37.16%	14,732 $1.62 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $969,728 - $1.12 Million	10,022 Added 74.67%	23,444 $2.27 Million
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $17.9 Million - $21.6 Million	-175,035 Reduced 92.88%	13,422 $1.46 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $18.5 Million - $22.6 Million	162,334 Added 621.42%	188,457 $22.3 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $1.97 Million - $2.42 Million	17,079 Added 188.84%	26,123 $3.68 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $34.3 Million - $37.9 Million	-293,861 Reduced 97.01%	9,044 $1.07 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $10.8 Million - $12.7 Million	101,699 Added 50.54%	302,905 $36.6 Million
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $21.8 Million - $25.7 Million	200,445 Added 26339.68%	201,206 $24.1 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $2.04 Million - $2.22 Million	-19,432 Reduced 96.23%	761 $83,000
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $2.15 Million - $2.61 Million	-23,432 Reduced 53.71%	20,193 $2.2 Million
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $2.36 Million - $3.02 Million	30,794 Added 240.0%	43,625 $3.99 Million
Q1 2020 May 14, 2020	BUY	$62.82 - $91.86 $689,700 - $1.01 Million	10,979 Added 592.82%	12,831 $1.01 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $2.37 Million - $2.64 Million	-30,190 Reduced 94.22%	1,852 $161,000
Q3 2019 Nov 13, 2019	BUY	$81.84 - $88.74 $2.54 Million - $2.75 Million	31,024 Added 3047.54%	32,042 $2.68 Million
Q2 2019 Aug 13, 2019	BUY	$72.88 - $85.0 $74,191 - $86,530	1,018 New	1,018 $86,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ossiam, based on Form 13F filings with the SEC.

News

Stay updated on Ossiam with notifications on news.

Account